DOI:
10.1055/s-00000068
Seminars in Interventional Radiology
LinksClose Window
References
Park JW, Kim YJ, Kim DY. et al.
Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: the phase III STAH trial.
J Hepatol 2019;
70 (04) 684-691
We do not assume any responsibility for the contents of the web pages of other providers.